why choose us

Clinical Trials Search

Showing 8,640 of 132,963 result(s)
The Longitudinal Study of Stimulant Use Disorder

Status: Completed

Condition: Stimulant Use

Interventions:

Date: 2023-09-15

Impact of Two Dietary Interventions on Simple Carbohydrate Intolerance

Status: Completed

Condition: Carbohydrate Intolerance

Interventions: Each participant will be following a low-FODMAP diet group for 3 weeks, followed by 3 week break prior to second diet intervention.

Date: 2023-09-15

Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.

Status: NOT_YET_RECRUITING

Condition: Chronic Myelomonocytic Leukemia

Interventions: CD4CAR cells transduced with a lentiviral vector to express the single-chain variable fragment (scFv) nucleotide sequence of the anti-CD4 molecule der

Date: 2023-09-15

Contribution of UGT2B17 to the Pharmacokinetics of Diclofenac

Status: NOT_YET_RECRUITING

Condition: Interaction

Interventions: 25 mg capsule

Date: 2023-09-15

Delivering Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding in Patients With and Without Von Willebrand Disease

Status: COMPLETED

Condition: Von Willebrand Disease, Type 1

Interventions: The Volta System will be using the components of the Sparrow Ascent device: (FDA-cleared K230796) a wearable, battery-operated, neurostimulation syste

Date: 2023-09-15

Pre-Visit Positive Imagery in Reducing Dental Anxiety

Status: COMPLETED

Condition: Dental Anxiety

Interventions: This picturebook will include pictures of the dental operatory and materials the patient can expect to see during their dental treatment appointment.<

Date: 2023-09-15

Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome

Status: COMPLETED

Condition: Gorlin Syndrome

Interventions: DRUG: Patidegib Topical Gel - Patidegib Gel 2% is a smooth, clear, colorless-to-yellow, viscous, hydro-alcoholic gel for topical administration.

Date: 2023-09-15

R-5280 in Newly Diagnosed Patients With Type 1 Diabetes

Status: COMPLETED

Condition: Type 1 Diabetes

Interventions: Modified Superior Starch

Date: 2023-09-15

A Study of CT-868 in Type 1 Diabetes Mellitus

Status: COMPLETED

Condition: Overweight

Interventions: CT-868 is an investigational medication administered subcutaneously via a pre-filled pen injector device.

Date: 2023-09-14

Effects of Fluid Resuscitation on Capillary Refilling Time and Organ Functions in Septic Shock

Status: COMPLETED

Condition: Sepsis

Interventions: In line with the recommendations in the Surviving Sepsis Guide, fingertip capillary refill time (CRT) will be measured by applying pressure to the ind

Date: 2023-09-14